CD44 and malignant colon neoplasm: In addition, we found increased expression of stem cell markers, including OCT4, Lin28, KLF, Bmi-1, CD44 and SOX2, in colon cancer cells upon treatment of BM-MSC-derived exosomes (Fig. 4d).